Apolipoprotein C3: form begets function.
Apolipoprotein C3: form begets function.
复制标题
DOI:
10.1016/j.jlr.2023.100475
复制
发表时间:
2024-01
影响因子:
6.5
通讯作者:
Bornfeldt, Karin E.
中科院分区:
文献类型:
--
作者:
Bornfeldt, Karin E.
Increased circulating levels of apolipoprotein C3 (APOC3) predict cardiovascular disease (CVD) risk in humans, and APOC3 promotes atherosclerosis in mouse models. APOC3’s mechanism of action is due in large part to its ability to slow the clearance of triglyceride-rich lipoproteins (TRLs) and their remnants when APOC3 is carried by these lipoproteins. However, different pools and forms of APOC3 exert distinct biological effects or associations with atherogenic processes. Thus, lipid-free APOC3 induces inflammasome activation in monocytes whereas lipid particle-bound APOC3 does not. APOC3-enriched LDL binds better to the vascular glycosaminoglycan biglycan than does LDL depleted of APOC3. Patterns of APOC3 glycoforms predict CVD risk differently. The function of APOC3 bound to HDL is largely unknown. There is still much to learn about the mechanisms of action of different forms and pools of APOC3 in atherosclerosis and CVD, and whether APOC3 inhibition would prevent CVD risk in patients on LDL-cholesterol lowering medications.
登录
查看更多内容
影响因子:
8.7
作者:
Bornfeldt, Karin E.
通讯作者:
Bornfeldt, Karin E.
影响因子:
4.5
作者:
Sumner AE;Furtado JD;Courville AB;Ricks M;Younger-Coleman N;Tulloch-Reid MK;Sacks FM
通讯作者:
Sacks FM
影响因子:
7.7
作者:
Hiukka A;Ståhlman M;Pettersson C;Levin M;Adiels M;Teneberg S;Leinonen ES;Hultén LM;Wiklund O;Oresic M;Olofsson SO;Taskinen MR;Ekroos K;Borén J
通讯作者:
Borén J
影响因子:
39.3
作者:
Alexander, Veronica J.;Xia, Shuting;Tsimikas, Sotirios
通讯作者:
Tsimikas, Sotirios
影响因子:
6.5
作者:
Cohn, JS;Rodriguez, C;Davignon, A
通讯作者:
Davignon, A